Search Orphan Drug Designations and Approvals
-
Generic Name: | 2-[4-(1-Methyl-4-pyridin-4-yl-lH-pyrazol-3-yl)-phenoxymethyl]-quinoline succinic acid |
---|---|
Date Designated: | 06/02/2014 |
Orphan Designation: | Treatment of Huntington's disease. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 04/02/2018 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Pfizer Inc. 445 Eastern Point Road Groton, Connecticut 06340 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-